Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company’s drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers. More information may be found at www.plustherapeutics.com and www.respect-trials.com.
Shared 4 months ago
109K views
Shared 6 months ago
82K views
Shared 7 months ago
835 views
Shared 11 months ago
417 views
Shared 1 year ago
268 views
Shared 1 year ago
495 views
Shared 1 year ago
3.2K views
Shared 1 year ago
309 views
Shared 1 year ago
2.8K views
Shared 1 year ago
333 views
Shared 2 years ago
191 views
Shared 2 years ago
177 views
Shared 3 years ago
36K views
Shared 3 years ago
115 views
Shared 3 years ago
1.9K views
Shared 3 years ago
2.2K views
Shared 4 years ago
163 views
Shared 4 years ago
68 views
Shared 4 years ago
91 views
Shared 4 years ago
51 views
Shared 4 years ago
58 views
Shared 4 years ago
963 views
Shared 4 years ago
60 views
Shared 5 years ago
499 views
Shared 5 years ago
24K views
Shared 5 years ago
105 views
Shared 5 years ago
15K views
Shared 5 years ago
73 views
Shared 5 years ago
62 views